Phase I/II Study of PDR001 in Patients With Advanced Malignancies

NCT02404441 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Non-small Sell Lung Cancer (NSCLC)
Triple Negative Breast Cancer
Anaplastic Thyroid Cancer
Other Solid Tumors

Interventions

BIOLOGICAL: PDR001

Sponsor

Novartis Pharmaceuticals